MaaT Pharma's total assets for Q2 2025 were €48.88M, an increase of 26.95% from the previous quarter. FR:MAAT total liabilities were €40.58M for the fiscal quarter, a 44.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.